1. Home
  2. NKTX vs BANX Comparison

NKTX vs BANX Comparison

Compare NKTX & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.16

Market Cap

168.2M

Sector

Health Care

ML Signal

HOLD

Logo ArrowMark Financial Corp.

BANX

ArrowMark Financial Corp.

HOLD

Current Price

$19.38

Market Cap

154.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
BANX
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
168.2M
154.9M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
NKTX
BANX
Price
$2.16
$19.38
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$11.33
N/A
AVG Volume (30 Days)
516.9K
36.5K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
11.88
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$18.45
52 Week High
$2.81
$23.67

Technical Indicators

Market Signals
Indicator
NKTX
BANX
Relative Strength Index (RSI) 45.59 50.81
Support Level $1.95 $18.55
Resistance Level $2.24 $19.52
Average True Range (ATR) 0.14 0.28
MACD 0.01 0.09
Stochastic Oscillator 41.94 80.24

Price Performance

Historical Comparison
NKTX
BANX

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.

Share on Social Networks: